 |
 |
 |
The Journal of the Japanese Society for Clinical Microbiology |
Biblioraphy Information
|
[Vol.19 No.3 contents] Japanese / English |
|
| ArticleTitle | A Case of Subcutaneous Port Infection Due to Mycobacterium fortuitum |
| Language | J |
| AuthorList | Toru Kawamura1), Akiko Miyazato2), Norihiro Iwasa3), Saori Seki1), Yoshitada Taji1), Masahiro Shimojima4), Yoshikazu Hashikita5), Noriyuki Watanabe5), Kotaro Mitsutake2), Kenji Ikebuchi1) |
| Affiliation |
1) Department of Laboratory Medicine 2) Department of Infectious Diseases and Infection Control 3) Department of Gynecologic Oncology, Saitama International Medical Center, Saitama Medical University 4) Bio Medical Laboratories, Inc. 5) Department of Laboratory Medicine, Saitama Medical University Hospital |
| Publication | J.J.C.M.: 19 (3), 177-181, 2009 |
| Received | March 16, 2009 |
| Accepted | July 1, 2009 |
| Abstract | A 39-year-old woman demonstrated abdominal pain and fever and was suspected of developing an infection from the infusion port subcutaneously implanted for chemotherapy of her ovarian cancer. The port was removed and subjected to a culture of microbes containing brain heart infusion broth (BHI). On the second day, acid-fast bacilli (AFB) smear-positive organisms had grown and were subsequently identified as Mycobacterium fortuitum. Susceptibility tests demonstrated that the isolate was resistant to imipenem (IPM, MIC 100 μg/ml) and clarithromycin (CAM, MIC> 100 μg/ml), although MIC of ciprofloxacin (CPFX), minocycline (MINO) and amikacin (AMK) were 0.2, 0.78 and 6.25 μg/ml, respectively. Removal of the infected device followed by combination therapy caused rapid improvement of the patient's symptoms. During the 6-month course of treatment, which included oral CPFX monotherapy, no recurrence was observed. |
| Keywords | Mycobacterium fortuitum |
| Copyright © 2002 The Japanese Society for Clinical Microbiology All rights reserved. |